首頁 > 市場調查報告書 > 醫療設備

體外診斷生技設備

聚合酵素鏈鎖反應(PCR) 市場規模、佔有率和成長分析（按類型、產品類型、適應症、最終用戶和地區分類）—2026-2033 年產業預測

市場調查報告書

商品編碼

1899318

聚合酵素鏈鎖反應(PCR) 市場規模、佔有率和成長分析（按類型、產品類型、適應症、最終用戶和地區分類）—2026-2033 年產業預測

Polymerase Chain Reaction (PCR) Market Size, Share, and Growth Analysis, By Type (Standard PCR, Real-time PCR), By Product (Instruments, Reagents & Consumables), By Indication, By End User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月24日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，聚合酵素鏈鎖反應(PCR) 市場規模將達到 109.5 億美元，到 2025 年將達到 118.7 億美元，到 2033 年將達到 226.3 億美元，預測期（2026-2033 年）的複合年成長率為 8.4%。

全球聚合酵素鏈鎖反應(PCR) 市場正經歷顯著擴張，並已成為分子生物學和診斷領域的關鍵技術。 PCR 能夠擴增和分析 DNA 和 RNA，使其在包括研究、臨床診斷、法醫學分析和生物技術在內的多種應用中發揮著至關重要的作用。成長要素包括感染疾病率的上升、對個人化醫療日益成長的需求、基因組學研究的進展以及對快速準確診斷工具的需求。眾多主要企業已進入市場，提供種類繁多的 PCR 儀器、耗材和服務。技術創新已將傳統的 PCR 方法發展為高效的自動化系統，例如即時PCR和數位 PCR，這些系統能夠提供更快的檢測結果和更高的靈敏度。此外，攜帶式PCR 設備正在擴大其在照護現場檢測環境中的市場進入。

聚合酵素鏈鎖反應(PCR) 市場促進因素

聚合酵素鏈鎖反應(PCR) 市場成長的主要驅動力在於其在分子診斷領域的廣泛應用，可用於識別和追蹤包括感染疾病、癌症和遺傳性疾病在內的多種疾病。近期全球健康挑戰凸顯了人們對精準快速診斷工具日益成長的需求，進一步推動了基於 PCR 的檢測和診斷解決方案的發展。隨著醫療系統和實驗室尋求可靠的方法來加強疾病的檢測和管理，這一趨勢預示著 PCR 市場將持續成長。因此，PCR 技術在現代醫學中的重要性日益凸顯，並促進了其廣泛應用。

聚合酵素鏈鎖反應（PCR）市場限制

PCR設備和耗材的高成本對小規模實驗室、診所和研究機構構成重大障礙。這種經濟負擔限制了PCR技術的普及，阻礙了其廣泛應用，尤其是在資源匱乏的地區。因此，價格承受能力問題限制了市場成長，尤其是在經濟拮据更為突出的發展中地區。投資這些關鍵工具的困難會阻礙監測和診斷技術的進步，並最終阻礙依賴PCR調查方法的醫療保健解決方案的發展。解決這些成本障礙對於擴大PCR技術在各種醫療保健環境中的應用範圍和有效性至關重要。

聚合酵素鏈鎖反應（PCR）市場趨勢

受對快速便捷診斷能力的需求不斷成長的推動，PCR市場正經歷著向照護現場（POC）解決方案的顯著轉變。這一趨勢主要源自於緊急情況下，尤其是在感染疾病防治領域，對快速檢測結果的需求。醫療機構正在積極尋求兼具檢測效率和即時結果的POC PCR檢測方案，這使得這些設備在臨床和社區醫療機構中都具有不可估量的價值。隨著及時診斷在醫療機構中持續佔據重要地位，POC PCR技術的應用預計將顯著成長，從而進一步鞏固其市場地位。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較

主要企業簡介

Abbott Laboratories（USA）
Agilent Technologies（USA）
Thermo Fisher Scientific（USA）
Siemens Healthineers（Germany）
bioMerieux（France）
Becton, Dickinson and Company（USA）
Bio-Rad Laboratories（USA）
Merck KGaA（Germany）
PerkinElmer（USA）
Promega Corporation（USA）
Danaher Corporation（USA）
QIAGEN（Netherlands）
QuantuMDx Group Ltd（UK）
Eppendorf（Germany）
Fluidigm Corporation（USA）
Microsynth AG（Switzerland）
JN Medsys（Singapore）
Takara Bio Inc（Japan）

結論與建議

簡介目錄

Product Code: SQMIG35H2241

Polymerase Chain Reaction (PCR) Market size was valued at USD 10.95 Billion in 2024 and is poised to grow from USD 11.87 Billion in 2025 to USD 22.63 Billion by 2033, growing at a CAGR of 8.4% during the forecast period (2026-2033).

The global polymerase chain reaction (PCR) market is experiencing significant expansion, emerging as an essential technology in molecular biology and diagnostics. PCR's adaptability for amplifying and analyzing DNA and RNA makes it vital across diverse applications, including research, clinical diagnostics, forensic analysis, and biotechnology. Key growth drivers include a rising incidence of infectious diseases, increasing demand for personalized medicine, advancements in genomics research, and the necessity for rapid and precise diagnostic tools. The market features numerous prominent players offering an extensive array of PCR equipment, consumables, and services. Innovations are leading traditional PCR methods towards more efficient automated systems, such as real-time and digital PCR, which provide quicker results and enhanced sensitivity. Moreover, portable PCR devices are broadening market access in point-of-care environments.

Top-down and bottom-up approaches were used to estimate and validate the size of the Polymerase Chain Reaction (PCR) market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Polymerase Chain Reaction (PCR) Market Segments Analysis

Global Polymerase Chain Reaction (PCR) Market is segmented by Type, Product, Indication, End User and region. Based on Type, the market is segmented into Standard PCR, Real-time PCR and Digital PCR. Based on Product, the market is segmented into Instruments and Reagents & Consumables. Based on Indication, the market is segmented into Infectious Diseases, Oncology, Genetic Disorders and Others. Based on End User, the market is segmented into Hospitals & Clinics, Pharmaceutical & Biotechnology Industries, Diagnostic Centers and Academic & Research Organizations. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Polymerase Chain Reaction (PCR) Market

The Polymerase Chain Reaction (PCR) market is significantly propelled by its widespread application in molecular diagnostics for the identification and tracking of various diseases, including infectious diseases, cancers, and genetic disorders. The increasing demand for accurate and timely diagnostic tools, especially highlighted by recent global health challenges, has escalated the need for PCR-based tests and diagnostic solutions. This trend illustrates a sustained growth trajectory for the PCR market, as healthcare systems and laboratories seek reliable methods to enhance disease detection and management. Consequently, the relevance of PCR technology in contemporary healthcare continues to strengthen, supporting its extensive utilization.

Restraints in the Polymerase Chain Reaction (PCR) Market

The high costs associated with PCR units and consumables present a significant obstacle for smaller laboratories, clinics, and research institutions. This financial burden limits access to PCR technology, particularly in resource-limited environments, hindering its widespread adoption. As a result, the affordability issue restricts market growth, especially in developing regions where financial constraints are more pronounced. The inability to invest in these essential tools may prevent advancements in research and diagnostics, ultimately impeding the overall progress of healthcare solutions reliant on PCR methodologies. Addressing these cost barriers is crucial for expanding the reach and effectiveness of PCR applications in various healthcare settings.

Market Trends of the Polymerase Chain Reaction (PCR) Market

The PCR market is experiencing a notable shift towards point-of-care (POC) testing solutions, driven by the increasing need for rapid and convenient diagnostic capabilities. This trend is largely fueled by the demand for swift results in critical situations, particularly in the context of infectious disease management. Healthcare providers are actively seeking POC PCR testing options that offer efficiency in testing and immediacy in results, making these devices invaluable in both clinical settings and community health initiatives. As the landscape of healthcare continues to prioritize timely diagnostics, the adoption of POC PCR technologies is expected to expand significantly, reinforcing their market presence.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Case Studies
Technological Advancement

Global Polymerase Chain Reaction (PCR) Market Size by Type & CAGR (2026-2033)

Market Overview
Standard PCR
Real-time PCR
Digital PCR

Global Polymerase Chain Reaction (PCR) Market Size by Product & CAGR (2026-2033)

Market Overview
Instruments
Reagents & Consumables

Global Polymerase Chain Reaction (PCR) Market Size by Indication & CAGR (2026-2033)

Market Overview
Infectious Diseases
Oncology
Genetic Disorders
Others

Global Polymerase Chain Reaction (PCR) Market Size by End User & CAGR (2026-2033)

Market Overview
Hospitals & Clinics
Pharmaceutical & Biotechnology Industries
Diagnostic Centers
Academic & Research Organizations

Global Polymerase Chain Reaction (PCR) Market Size & CAGR (2026-2033)

North America (Type, Product, Indication, End User)
- US
- Canada
Europe (Type, Product, Indication, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Type, Product, Indication, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Type, Product, Indication, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Type, Product, Indication, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Abbott Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
bioMerieux (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Promega Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
QIAGEN (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
QuantuMDx Group Ltd (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eppendorf (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fluidigm Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Microsynth AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
JN Medsys (Singapore)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Takara Bio Inc (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments